Versions :<12345Live>
Snapshot 4:Thu, Sep 4, 2025 8:13:39 PM GMT last edited by Nick

RFK Jr. Faces Bipartisan Congressional Criticism Over CDC, Vaccine Policies

RFK Jr. Faces Bipartisan Congressional Criticism Over CDC, TurmoilVaccine Policies

RFK Jr. Faces Bipartisan Congressional Criticism Over CDC, Vaccine Policies
Above: U.S. Health Secretary Robert F. Kennedy Jr. at a Senate hearing in Washington, D.C., on Sept. 4, 2025. Image credit: Kayla Bartkowski/Bloomberg/Getty Images

The Spin

Lawmakers rightly grilled RFK Jr.'s foractions attackingat publicHHS health.are Asa HHSbold secretary,stand heagainst Big Pharma's firedgrip CDCon workerspublic health. Lawmakers, weakenedlikely diseasefunded prevention,by downplayedthe vaccines$388 duringmillion outbreakspharma lobbying machine, andare endedpredictably globaloutraged vaccinationas support.he Hisslashes anti-sciencecorrupt actionscorporate capture, notably firing DirectorCDC Monarezstaff fortied upholdingto evidence,the endangerindustry lives,and especiallychallenging foruntested low-incomevaccine familiesmandates. CongressHis mustpush actfor tosafer protectfood, thebetter CDC'sexercise 80-yearand missionrigorous anddrug testing prioritizes Americans over profits, despite bipartisan resistance fueled by pharma's health$8.1B ad empire.

Lawmakers rightly grilled RFK Jr.'s actionsfor atattacking HHSpublic arehealth. aAs boldHHS standsecretary, against Big Pharmahe's gripfired onCDC public health. Lawmakersworkers, likelyweakened fundeddisease byprevention, thedownplayed $388Mvaccines pharmaduring lobbying machineoutbreaks, areand predictablyended outragedglobal asvaccination hesupport. slashesHis corruptanti-science corporate captureactions, notably firing CDCDirector staffMonarez tiedfor toupholding theevidence, industryendanger andlives challenging untestedespecially vaccinefor mandateslow-income families. HisCongress pushmust foract saferto food,protect betterthe exerciseCDC's and80-year rigorousmission drugand testing prioritizes Americans over profits, despite bipartisan resistance fueled by pharma's $8health.1B ad empire.


Articles on this story



© 2026 Improve the News Foundation. All rights reserved.Version 6.18.0

© 2026 Improve the News Foundation.

All rights reserved.

Version 6.18.0